Price Crosses Moving Average
|Bid||8.15 x 4000|
|Ask||8.42 x 3200|
|Day's Range||8.22 - 8.32|
|52 Week Range||5.59 - 9.05|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||27.53|
|Forward Dividend & Yield||0.06 (0.70%)|
|Ex-Dividend Date||Mar 16, 2023|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for HLNLearn more
HLN vs. SYK: Which Stock Is the Better Value Option?
GSK Plc (NYSE: GSK) sold 240 million shares of its spun-out consumer healthcare group Haleon Plc (NYSE: HLN) in a move that has raised £804 million for the firm. The offloaded shares are equivalent to up to 2.5% of Haleon's issued share capital. Following the settlement of the placing, GSK will hold 955 million ordinary shares in Haleon, representing approximately 10.3% of its issued share capital. GSK and Pfizer Inc (NYSE: PFE) – which hold a 32% stake in Haleon – have each undertaken not to di
The latest investor updates on stocks that are trending on Friday.
Pfizer Inc (NYSE: PFE) is reportedly looking to start selling its stake in Haleon plc (NYSE: HLN). In June last, the pharma giant announced its plans to exit the ownership interest in Haleon in a disciplined manner after the demerger. Pfizer's CFO, Dave Denton, told the Financial Times that it intends to offload that stake in a "slow and methodical" manner within months. Pfizer retained its 32% stake in Haleon. GSK Plc (NYSE: GSK) has up to 13.5% in Haleon, while GSK shareholders will own the re
Haleon, the world's biggest standalone consumer health business, on Wednesday reported first-quarter profit below analyst expectations, hurt by higher costs. The company, which sells non-prescription drugs, vitamins and oral care products, said it generated earnings per share of 4.2 pence on revenue of nearly 3 billion pounds. Organic revenue growth of 9.9% in the quarter was largely driven by price increases, but also a small rise in volumes.
The consumer health company features a range of leading brands, a relatively cheap valuation, a solid balance sheet, consistent earnings, and a healthy dividend yield. It’s no tech unicorn, a good thing in 2023.
On Monday afternoon, Johnson & Johnson which owns each of these brands, put a number on it: About $40 billion. Johnson & Johnson is pricing the IPO at between $20 and $23 per share, and expects to raise about $3.2 billion. At a valuation of $40 billion, Kenvue represents about 9% of Johnson & Johnson’s current market value f $426 billion.
Key Insights The projected fair value for Haleon is UK£3.15 based on 2 Stage Free Cash Flow to Equity Haleon's UK£3.45...
Aristotle Capital Management, LLC, an investment management company, released its “Global Equity Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund returned 12.67% net of fees, compared to a 9.77% return for the MSCI World Index (net) and a 9.76% return for the MSCI ACWI […]
Haleon plc ( LON:HLN ) insiders who purchased shares in the last 12 months were richly rewarded last week. The stock...
Nearly four months after a federal court ruling eased investors' concerns, a decision by a state judge in California has reignited those fears.
Shareholders might have noticed that Haleon plc ( LON:HLN ) filed its annual result this time last week. The early...
Consumer healthcare group Haleon's Chief Executive Brian McNamara said on Thursday he does not expect to announce any acquisitions or divestments imminently, amid analyst concerns its 2023 cost forecasts could hit consensus profit estimates. McNamara told Reuters that both types of transactions were on the cards, but added "there's certainly nothing imminent that is out there that I would talk about today". Haleon, carved out of British drugmaker GSK in July in the biggest listing in Europe for more than a decade, is the world's biggest standalone consumer health business selling non-prescription drugs, vitamins and oral care products.
Haleon, the world's biggest standalone consumer health business with brands such as Sensodyne toothpaste and Advil painkillers, on Thursday forecast 4-6% organic revenue growth in 2023. In its first full-year results, CEO Brian McNamara said Haleon had navigated a highly volatile environment. Players in the consumer health field, like other sectors, have had to contend with sharp cost increases across the business, including raw materials, transport and energy linked to the war in Ukraine and lingering COVID-19 disruptions.
A look at the shareholders of Haleon plc ( LON:HLN ) can tell us which group is most powerful. The group holding the...
In this article, we discuss 10 recent spin-off companies that hedge funds are piling into. If you want to see more stocks in this selection, check out 5 Recent Spin-off Companies That Hedge Funds Are Piling Into. A spin-off occurs when a company splits off a portion of its business into a separate company and […]
Cooper Investors, an investment management firm, released its “Cooper Investors Global Equities Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. The fund returned 6.24% in the fourth quarter, compared to a 7.08% return for the benchmark MSCI ACWI. For the year 2022, the fund returned -24.69% compared to a […]
GSK's specialty products like Dovato, Nucala, Trelegy Ellipta and Shingrix are likely to drive sales, making up for the lower sales of established drugs due to generic erosion.
In this article, we will take a look at the 12 best 52-week high stocks to buy now. If you want to see more stocks in this selection, go to the 5 Best 52-Week High Stocks To Buy Now. The equity markets have been taking a beating this year as the Dow Jones Industrial Average […]
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
In this article, we discuss 10 best medical stocks under $20. If you want to see more stocks in this selection, check out 5 Best Medical Stocks Under $20. The healthcare industry has undergone a significant restructuring in the wake of the COVID-19 pandemic. There were multiple new healthcare trends in 2022 that have a […]
Market noise has been loud this year and it has been difficult for investors to look beyond the hysteria whipped up by their peers to focus on information and fundamentals. Sentiment has also been highly changeable, which has led to volatile stock prices that in many cases materially diverge from underlying business valuations.
Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quarter investor letter. A copy of the same can be downloaded here. In the third quarter, the fund declined -10.05%, underperforming the MSCI ACWI Index and the MSCI ACWI Value Index, which returned -6.82% and -7.66%, respectively. Multiple headwinds from all over the world affected […]
Aristotle Capital Management, LLC, an investment management company, released its “International Equity Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund returned ‐7.90% gross of fees, compared to a ‐9.36% return for the MSCI EAFE Index and ‐9.91% return for the MSCI ACWI ex USA […]
Haleon ( LON:HLN ) Third Quarter 2022 Results Key Financial Results Net income: UK£345.0m (up by UK£345.0m from 3Q...